The efficacy and safety of different does of intravenous tranexamic acid on blood loss in fresh foot and ankle fractures: a prospective, randomized controlled study

被引:1
作者
Tan, Gang [1 ,2 ,3 ]
Li, Jia [1 ]
Xu, Jing [4 ]
Zhu, Yongzhan [5 ]
Zhang, Hui [1 ]
机构
[1] Sichuan Univ, Dept Orthopaed, West China Hosp, 37 Guoxue lane, Chengdu 610041, Sichuan, Peoples R China
[2] Sichuan Univ, West China Sch Publ Hlth, Dept Orthopaed, Chengdu, Sichuan, Peoples R China
[3] Sichuan Univ, West China Hosp 4, Dept Orthopaed, Chengdu, Sichuan, Peoples R China
[4] Sichuan Univ, West China Hosp, West China Sch Nursing, Operating Room, Chengdu 610041, Peoples R China
[5] Foshan Hosp Tradit Chinese Med, Foshan, Guangdong, Peoples R China
关键词
Tranexamic acid; Efficacy and safety; Different does; Blood loss; Fresh foot and ankle fractures; TRAUMA PATIENTS; TRANSFUSION; CRASH-2;
D O I
10.1186/s12891-024-07410-4
中图分类号
R826.8 [整形外科学]; R782.2 [口腔颌面部整形外科学]; R726.2 [小儿整形外科学]; R62 [整形外科学(修复外科学)];
学科分类号
摘要
Background There are a few studies on the effectiveness and safety of intravenous administration of tranexamic acid(TXA) in patients who underwent foot and ankle surgery, especially for preoperative hidden blood loss in patients with freshfoot and ankle fractures. Thus, the aim of this study was to investigate whether intravenous administration of different doses of TXA can effectively reduce perioperative blood loss and blood loss before surgery and to determine its safety.Methods A total of 150 patients with fresh closed foot and ankle fractures from July 2021 to July 2023 were randomly divided into a control group (placebo controlled [PC]), standard-dose group (low-dose group [LD], 1 g/24 h; medium-dose group [MD], 2 g/24 h), and high-dose group (HD, 3 g/24 h; ultrahigh-dose group [UD], 4 g/24 h). After admission, all patients completed hematological examinations as soon as possible and at multiple other time points postsurgery.Results There was a significant difference in the incidence of hidden blood loss before the operation between the TXA group and the control group, and the effect was greater in the overdose groups than in the standard-dose groups. There were significant differences in surgical blood loss (intraoperative and postoperative), postoperative HGB changes, and hidden blood loss among the groups. The TXA groups showed a significant decrease in blood loss compared to that of the control group, and the overdose groups had a more significant effect than the standard-dose groups. A total of 9 patients in the control group had early wound infection or poor healing, while only 1 patient in the other groups had this complication, and the difference among the groups was significant. No patients in any group suffered from late deep wound infection, cardiovascular or cerebrovascular events or symptomatic VTE.Conclusion This is the first study on whether TXA can reduce preoperative hidden blood loss in patients with freshfoot and ankle fractures. In our study, on the one hand, intravenous application of TXA after foot and ankle fractures as soon as possible can reduce preoperative blood loss and postoperative blood loss. On the other hand, TXA can also lower wound complications, and over-doses of TXA are more effective than standard doses. Moreover, overdoses of TXA do not increase the incidence of DVT.
引用
收藏
页数:10
相关论文
共 38 条
  • [1] Use of tranexamic acid does not influence perioperative outcomes in ambulatory foot and ankle surgery-a prospective triple blinded randomized controlled trial
    B.H, Poonam Pai
    Diskina, Dina
    Lin, Hung Mo
    Vulcano, Ettore
    Lai, Yan H.
    [J]. INTERNATIONAL ORTHOPAEDICS, 2021, 45 (09) : 2277 - 2284
  • [2] Association of tranexamic acid with decreased blood loss in patients undergoing laminectomy and fusion with posterior instrumentation: a systematic review and meta-analysis
    Brown, Nolan J.
    Choi, Elliot H.
    Gendreau, Julian L.
    Ong, Vera
    Himstead, Alexander
    Lien, Brian, V
    Shahrestani, Shane
    Ransom, Seth C.
    Tran, Katelynn
    Tafreshi, Ali R.
    Sahyouni, Ronald
    Chan, Alvin
    Oh, Michael Y.
    [J]. JOURNAL OF NEUROSURGERY-SPINE, 2022, 36 (04) : 686 - 693
  • [3] Tranexamic Acid Reduces Blood Loss and Blood Transfusion after TKA: A Prospective Randomized Controlled Trial
    Charoencholvanich, Keerati
    Siriwattanasakul, Pichet
    [J]. CLINICAL ORTHOPAEDICS AND RELATED RESEARCH, 2011, 469 (10) : 2874 - 2880
  • [4] Risk of venous and arterial thrombosis in non-surgical patients receiving systemic tranexamic acid: A systematic review and meta-analysis
    Chornenki, Nicholas L. Jackson
    Um, Kevin J.
    Mendoza, Pablo A.
    Samienezhad, Ashkan
    Swarup, Vidushi
    Chai-Adisaksopha, Chatree
    Siegal, Deborah M.
    [J]. THROMBOSIS RESEARCH, 2019, 179 : 81 - 86
  • [5] The Efficacy and Safety of Intravenous Tranexamic Acid in Reducing Surgical Blood Loss in Posterior Lumbar Interbody Fusion for the Adult: A Systematic Review and a Meta-Analysis
    Gong, Min
    Liu, Guoming
    Chen, Li
    Chen, Ran
    Xiang, Zhou
    [J]. WORLD NEUROSURGERY, 2019, 122 : 559 - 568
  • [6] ESTIMATING ALLOWABLE BLOOD-LOSS - CORRECTED FOR DILUTION
    GROSS, JB
    [J]. ANESTHESIOLOGY, 1983, 58 (03) : 277 - 280
  • [7] A Single Preoperative Dose of Tranexamic Acid Reduces Perioperative Blood Loss A Meta-analysis
    Heyns, Mieke
    Knight, Paige
    Steve, Anna K.
    Yeung, Justin K.
    [J]. ANNALS OF SURGERY, 2021, 273 (01) : 75 - 81
  • [8] Tranexamic acid can reduce blood loss in patients undergoing intertrochanteric fracture surgery: A meta-analysis
    Jiang, Wenming
    Shang, Liyong
    [J]. MEDICINE, 2019, 98 (11)
  • [9] Johns William L, 2020, Foot Ankle Orthop, V5, p2473011420975419, DOI 10.1177/2473011420975419
  • [10] Tranexamic acid is associated with reduced mortality, hemorrhagic expansion, and vascular occlusive events in traumatic brain injury - meta-analysis of randomized controlled trials
    July, Julius
    Pranata, Raymond
    [J]. BMC NEUROLOGY, 2020, 20 (01)